2024/09/19 22:30:00 | |
---|---|
Price | |
1.2437 USD | |
Difference | -0.50% (-0.01) |
ISIN | CA10919W4056 |
Symbol | DRUG |
Exchange | Nasdaq |
Currency | USD |
Sector | - |
Security type | Stock |
Market cap (m) | 5 EUR |
Benchmark | S&P/TSX 60 INDEX |
Bid (Bid size) | 1.16 USD (100) |
Ask (Ask size) | 1.40 USD (2,000) |
Open | 1.30 USD |
High | 1.30 USD |
Low | 1.1501 USD |
Close (prev. day) | 1.25 USD |
VWAP | 1.222913 USD |
Volume (pcs) | 43,069 |
Trading volume | 52,659.83 |
Number of trades | 140 |
Last size | - |
Related Futures | - |
Related Options | - |
2024/09/19 22:30:00 | |
---|---|
Price | |
1.2437 USD | |
Difference | -0.50% (-0.01) |
ISIN | CA10919W4056 |
Symbol | DRUG |
Exchange | Nasdaq |
Currency | USD |
Sector | - |
Security type | Stock |
Market cap (m) | 5 EUR |
Benchmark | S&P/TSX 60 INDEX |
Bid (Bid size) | 1.16 USD (100) |
Ask (Ask size) | 1.40 USD (2,000) |
Open | 1.30 USD |
High | 1.30 USD |
Low | 1.1501 USD |
Close (prev. day) | 1.25 USD |
VWAP | 1.222913 USD |
Volume (pcs) | 43,069 |
Trading volume | 52,659.83 |
Number of trades | 140 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | +1.94% | -27.69% | -95.86% |
Perf (abs.) | +0.02 | -0.48 | -28.80 |
Beta | 1.15 | 0.77 | 1.25 |
Volatility | 91.20 | 83.60 | 122.50 |
Ø price 5 days | Ø volume 5 days (pcs.) | 1.2597 USD (23,616) |
Ø price 30 days | Ø volume 30 days (pcs.) | 1.1336 USD (190,064) |
Ø price 100 days | Ø volume 100 days (pcs.) | 1.1074 USD (72,787) |
Ø price 250 days | Ø volume 250 days (pcs.) | 1.3675 USD (44,956) |
YTD High | date | 2.3900 USD (2024/02/05) |
YTD Low | date | 0.9300 USD (2024/04/30) |
52 Weeks High | date | 2.3900 USD (2024/02/05) |
52 Weeks Low | date | 0.9300 USD (2024/04/30) |
- |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer